Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Glycerophospholipids [GP]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMGP20010044 P-IsoPGJ2-PC 1-hexadecanoyl-2-(11-oxo-15-hydroxy-5Z,9,13E-prostatrienoyl)-sn-glycero-phosphocholine PC 36:5;O2 C44H78NO10P 811.536336
LMGP20010044 P-IsoPGJ2-PC 1-hexadecanoyl-2-(11-oxo-15-hydroxy-5Z,9,13E-prostatrienoyl)-sn-glycero-phosphocholine PC 36:5;O2 C44H78NO10P 811.536336
LMGP20010020 PHODA-PC 1-hexadecanoyl-2-(9-hydroxy-12-oxo-10E-dodecenoyl)-sn-glycero-3-phosphocholine PC 28:2;O2 C36H68NO10P 705.458086
LMGP20010020 PHODA-PC 1-hexadecanoyl-2-(9-hydroxy-12-oxo-10E-dodecenoyl)-sn-glycero-3-phosphocholine PC 28:2;O2 C36H68NO10P 705.458086
LMGP01030144 PC P-18:1(9Z)/16:0 1-(1Z,9Z-octadecadienyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine PC O-34:2 C42H82NO7P 743.582891
LMGP02030032 PE P-16:0/22:2(13Z,16Z) 1-(1Z-hexadecenyl)-2-(13Z,16Z-docosadienoyl)-glycero-3-phosphoethanolamine PE O-38:3 C43H82NO7P 755.582891
LMGP02030095 PE P-16:0/18:1(9Z) 1-(1Z-hexadecenyl)-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine PE O-34:2 C39H76NO7P 701.535941
LMGP02030135 PE P-18:1(9Z)/20:2(11Z,14Z) 1-(1Z,9Z-octadecadienyl)-2-(11Z,14Z-eicosadienoyl)-glycero-3-phosphoethanolamine PE O-38:4 C43H80NO7P 753.567241
LMGP02030136 PE P-18:1(9Z)/20:3(8Z,11Z,14Z) 1-(1Z,9Z-octadecadienyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphoethanolamine PE O-38:5 C43H78NO7P 751.551591
LMGP02030142 PE P-16:0/22:5(7Z,10Z,13Z,16Z,19Z) 1-(1Z-hexadecenyl)-2-(7Z,10Z,13Z,16Z,19Z-docosatrienoyl)-glycero-3-phosphoethanolamine PE O-38:6 C43H76NO7P 749.535941
LMGP02030137 PE P-18:0/20:4(8Z,11Z,14Z,17Z) 1-(1Z-octadecenyl)-2-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-glycero-3-phosphoethanolamine PE O-38:5 C43H78NO7P 751.551591
LMGP02030138 PE P-18:1(9Z)/20:4(8Z,11Z,14Z,17Z) 1-(1Z,9Z-octadecadienyl)-2-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-glycero-3-phosphoethanolamine PE O-38:6 C43H76NO7P 749.535941
LMGP02030139 PE P-18:1(11Z)/20:4(8Z,11Z,14Z,17Z) 1-(1Z,11Z-octadecadienyl)-2-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-glycero-3-phosphoethanolamine PE O-38:6 C43H76NO7P 749.535941
LMGP02030140 PE P-18:1(11Z)/20:4(5Z,8Z,11Z,14Z) 1-(1Z,11Z-octadecadienyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycero-3-phosphoethanolamine PE O-38:6 C43H76NO7P 749.535941
LMGP02030141 PE P-16:0/22:5(4Z,7Z,10Z,13Z,16Z) 1-(1Z-hexadecenyl)-2-(4Z,7Z,10Z,13Z,16Z-docosatrienoyl)-glycero-3-phosphoethanolamine PE O-38:6 C43H76NO7P 749.535941
LMGP02030148 PE P-18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z) 1-(1Z,9Z-octadecadienyl)-2-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-glycero-3-phosphoethanolamine PE O-40:7 C45H78NO7P 775.551591
LMGP01030026 PC P-16:0/16:1(9Z) 1-(1Z-hexadecenyl)-2-(9Z-hexadecenoyl)-glycero-3-phosphocholine PC O-32:2 C40H78NO7P 715.551591
LMGP02030162 PE P-16:0/22:3(7Z,10Z,13Z) 1-(1Z-hexadecenyl)-2-(7Z,10Z,13Z-docosatrienoyl)-sn-glycero-3-phosphoethanolamine PE O-38:4 C43H80NO7P 753.567241
LMGP01030013 PC P-18:0/18:1(9Z) 1-(1Z-octadecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine PC O-36:2 C44H86NO7P 771.614191
LMGP01020281 PC O-16:0/18:1(11Z) 1-hexadecyl-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine PC O-34:1 C42H84NO7P 745.598541
LMGP02010567 PE 17:1(9Z)/16:0 1-(9Z-heptadecenoyl)-2-hexadecanoyl-glycero-3-phosphoethanolamine PE 33:1 C38H74NO8P 703.515206
LMGP06050002 PI 16:0/0:0 1-hexadecanoyl-sn-glycero-3-phospho-(1'-myo-inositol) LPI 16:0 C25H49O12P 572.296167
LMGP06010837 PI 19:0/19:0 1,2-dinonadecanoyl-sn-glycero-3-phospho-(1'-myo-inositol) PI 38:0 C47H91O13P 894.619732
LMGP01010927 PC 18:2(6Z,9Z)/18:2(6Z,9Z) 1,2-di-(6Z,9Z-octadecadienoyl)-sn-glycero-3-phosphocholine PC 36:4 C44H80NO8P 781.562156
LMGP01011270 PC 9:0/9:0 1,2-dinonanoyl-sn-glycero-3-phosphocholine PC 18:0 C26H52NO8P 537.343055
LMGP01012063 PC 22:2(13Z,16Z)/22:2(13Z,16Z) 1,2-di-(13Z,16Z-docosadienoyl)-sn-glycero-3-phosphocholine PC 44:4 C52H96NO8P 893.687356
LMGP01012163 PC 18:1(9Z)/18:1(11Z) 1-(9Z-octadecenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine PC 36:2 C44H84NO8P 785.593456
LMGP03010863 PS 20:0/20:0 1,2-dieicosanoyl-sn-glycero-3-phosphoserine PS 40:0 C46H90NO10P 847.630236
LMGP04010024 PG 15:0/15:0 1,2-dipentadecanoyl-sn-glycero-3-phospho-(1'-sn-glycerol) PG 30:0 C36H71O10P 694.478487
LMGP24010001 PT 18:1(9Z)/18:1(9Z) 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphothreonine PT 36:2 C43H80NO10P 801.551986
LMGP02010343 PE-NMe(14:0/14:0) 1,2-ditetradecanoyl-sn-glycero-3-phospho-N-methylethanolamine PE-NMe 28:0 C34H68NO8P 649.468256
LMGP15010099 PIM3(16:0/16:0) 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol) PIM3 32:0 C59H109O28P 1296.684308
LMGP15010018 PIM1(18:0/18:0) 2'-O-(alpha-D-Manp)-(1,2-dioctadecanoyl-sn-glycero-3-phospho-1'-myo-inositol) PIM1 36:0 C51H97O18P 1028.641257
LMGP01010871 PC 18:1(7Z)/18:1(7Z) 1,2-di-(7Z-octadecenoyl)-sn-glycero-3-phosphocholine PC 36:2 C44H84NO8P 785.593456
LMGP01011043 PC 20:1(9Z)/20:1(9Z) 1,2-di-(9Z-eicosenoyl)-sn-glycero-3-phosphocholine PC 40:2 C48H92NO8P 841.656056
LMGP01011856 PC 20:2(11Z,14Z)/20:2(11Z,14Z) 1,2-di-(11Z,14Z-eicosadienoyl)-sn-glycero-3-phosphocholine PC 40:4 C48H88NO8P 837.624756
LMGP03010021 PS 8:0/8:0 1,2-dioctanoyl-sn-glycero-3-phosphoserine PS 16:0 C22H42NO10P 511.254635
LMGP03010166 PS 15:1(9Z)/15:1(9Z) 1,2-di-(9Z-pentadecenoyl)-sn-glycero-3-phosphoserine PS 30:2 C36H66NO10P 703.442436
LMGP03010380 PS 18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z) 1,2-di-(6Z,9Z,12Z-octadecatrienoyl)-sn-glycero-3-phosphoserine PS 36:6 C42H70NO10P 779.473736
LMGP04010409 PG 18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z) 1-(9Z,12Z,15Z-octadecatrienoyl)-2-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phospho-(1'-sn-glycerol) PG 36:6 C42H71O10P 766.478487
LMGP04010977 PG 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z) 1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-(1'-sn-glycerol) PG 44:12 C50H75O10P 866.509787
LMGP02010338 PE-NMe 18:1(9Z)/18:1(9Z) 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phospho-N-methylethanolamine PE-NMe 36:2 C42H80NO8P 757.562156
LMGP15010051 PIM2(16:0/16:0) 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol) PIM2 32:0 C53H99O23P 1134.631482
LMGP06010827 PI 20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z) 1,2-di-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) PI 40:8 C49H79O13P 906.525832
LMGP06010829 PI 20:1(11Z)/20:1(11Z) 1,2-di-(11Z-eicosenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) PI 40:2 C49H91O13P 918.619732
LMGP03010020 PS 6:0/6:0 1,2-dihexanoyl-sn-glycero-3-phosphoserine PS 12:0 C18H34NO10P 455.192035
LMGP03010579 PS 20:2(11Z,14Z)/20:2(11Z,14Z) 1,2-di-(11Z,14Z-eicosadienoyl)-sn-glycero-3-phosphoserine PS 40:4 C46H82NO10P 839.567636
LMGP03010860 PS 20:1(11Z)/20:1(11Z) 1,2-di-(11Z-eicosenoyl)-sn-glycero-3-phosphoserine PS 40:2 C46H86NO10P 843.598936
LMGP03010890 PS 17:2(9Z,12Z)/17:2(9Z,12Z) 1,2-di-(9Z,12Z-heptadecadienoyl)-sn-glycero-3-phosphoserine PS 34:4 C40H70NO10P 755.473736
LMGP04010858 PG 20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z) 1,2-di-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-sn-glycerol) PG 40:8 C46H75O10P 818.509787